Colon cancer is a prevalent cause of cancer-related deaths, often originating from polyps in the colon or rectum. Detecting and removing these polyps early is crucial since most colon cancers stem from them. Fortunately, colon cancer is highly preventable and treatable, with a 90% survival rate when caught early.
Without screening, undetected cancers can progress to advanced stages, leading to poorer outcomes. It is estimated that colon cancer will claim 53,000 lives in 2025, highlighting the importance of regular screening.
The American Cancer Society now recommends individuals at average risk to begin regular colon cancer screening at age 45, considering the rising rates of colon cancer in younger adults. However, those with specific risk factors or family history may need to start screening earlier.
Screening options for colon cancer include colonoscopy, flexible sigmoidoscopy, CT colonography, capsule endoscopy, fecal immunochemical test (FIT), guaiac-based fecal occult blood test, and stool DNA test (Cologuard). Each method has its advantages and limitations, so it’s essential to discuss with your healthcare provider to determine the most suitable option.
The frequency of colon cancer screening varies depending on individual risk factors and previous findings. Regular screening is crucial to monitor for any changes in the colon and detect any abnormalities early.
In conclusion, regular screening for colon cancer is vital in reducing the incidence and mortality rates associated with the disease. The choice of screening method should be based on individual risk factors, preferences, and accessibility to testing. It is essential not to delay screening to ensure early detection and effective treatment.
